BIO-key International closed at $2.37 on Nov 4, down 4.38%, 99.5% below its highest close since Jul 25. Volume of 76.5K shares was 0.01× its 20-day average (below normal).
Split-adjusted performance: +30.3% over one month, -54.6% over six months.
In the quarter ended Jun 30, 2026, revenue was $1.92M, up 13.1% from a year earlier, with a net margin of -30.0%.
Short interest was 386.5K shares at the Oct 15 settlement, down 61.2% from the prior report (21.0% of float, 1.0 days to cover).